-
Mashup Score: 16Ekspert FDA: przyspieszona lub warunkowa rejestracja jest możliwa. Ale leki nieskuteczne można usunąć z rynku - 10 day(s) ago
Agencje rejestrujące leki, takie jak FDA czy EMA, mogą dopuszczać leki w procedurze przyspieszonej lub warunkowo. Bywa, że jeśli lek okaże się nieskuteczny, może zostać usunięty z rynku – opowiada dr Richard Pazdur z FDA.
Source: www.rynekzdrowia.plCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4OCE Oncology News - 11 day(s) ago
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Asian Americans, Native Hawaiian, and Other Pacific Islanders - 11 day(s) ago
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Project Significant - 11 day(s) ago
Promoting collaboration in design and analysis of cancer clinical trials
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Asian Americans, Native Hawaiian, and Other Pacific Islanders - 12 day(s) ago
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Project Facilitate - 13 day(s) ago
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4OCE Oncology News - 13 day(s) ago
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
Coverage of FDA Oncology Center Director Richard Pazdur's recent visit to Poland. @rynekzdrowia @realrickpazdur https://t.co/9DwAzVcii2